🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

265 results for “LG” Clear

  1. Nerve block with liposomal bupivacaine and intravenous analgesia

    The First People's Hospital of Lianyungang

    Liposomal Bupivacaine

    approved other active

    1 trial

  2. Oxycodone Hydrochloride

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule active

    1 trial

  3. Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane

    Novo Nordisk A/S

    Knee osteoarthritis

    approved small molecule active

    1 trial

  4. Realgar-Indigo Naturalis Formulation Combined with Anlotinib

    The First People's Hospital of Lianyungang

    Platinum-resistant Ovarian Cancer (PROC)

    approved small molecule active

    1 trial

  5. S-ketamine & Ropivacaine

    The First People's Hospital of Lianyungang

    Postoperative Analgesia

    approved small molecule active

    1 trial

  6. Sarilumab

    Regeneron UK Limited

    Polymyalgia Rheumatica

    approved small molecule active

    1 trial

  7. Search AV+ algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Sinus

    approved other terminated

    1 trial

  8. Treatment Algorithm A

    Takeda

    Colitis, Ulcerative

    approved mab active

    1 trial

  9. Triptergium Wilfordii

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis Vulgaris

    approved small molecule active

    1 trial

  10. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease (Infantile-Onset)

    approved mab terminated

    1 trial

  11. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease

    approved mab completed

    1 trial

  12. intravenous sufentanil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule completed

    1 trial

  13. A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

    The First People's Hospital of Lianyungang

    Anal Fistula

    small molecule active

    1 trial

  14. Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm

    The First People's Hospital of Lianyungang

    Ovarian Cancer

    other active

    1 trial

  15. Chronotropic Incompetence Diagnostic Algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    other terminated

    1 trial

  16. Dexmedetomidine supplemented morphine analgesia

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Elderly

    small molecule completed

    1 trial

  17. Esketamine, Sulfentanil or/and Remifentanil

    Second Affiliated Hospital of Soochow University

    Opioid Analgesic Adverse Reaction

    small molecule active

    1 trial

  18. Guselkumab

    BRIGHT MINDS BIOSCIENCES INC.

    Psoriasis Vulgaris

    small molecule terminated

    1 trial

  19. Ivarmacitinib tablet

    The First People's Hospital of Lianyungang

    Polymyalgia Rheumatics (PMR)

    small molecule active

    1 trial

  20. Pregabalin capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Fibromyalgia

    small molecule completed

    1 trial

  21. Remimazolam

    The First People's Hospital of Lianyungang

    Sedation and Analgesia

    small molecule active

    1 trial

  22. Sana Device (Control)

    Sana Biotechnology

    Fibromyalgia

    small molecule terminated

    1 trial

  23. YishenShujin Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Fibromyalgia Syndrome

    small molecule active

    1 trial

  24. esketamine group

    The First People's Hospital of Lianyungang

    Postherpetic Neuralgia

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources